结核病管理和控制的概念框架的开发;使用文本挖掘软件的证据综合:一篇评论
Sri Handayani1, Reece Hinchcliff2, Zainal A Hasibuan3
1Department of Public Health, Faculty of Health, Universitas Dian Nuswantoro, Semarang, Indonesia.
Iranian journal of public health
|March 4, 2024
概括
这项研究探讨了电子系统和文本挖掘的结核病 (TB) 战略. 研究结果强调了早期检测和治疗,以尽量减少结核病的传播,特别是在弱势群体中.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 医疗信息学 医疗信息学
背景情况:
- 消除结核病 (TB) 战略需要探索电子系统和文本挖掘软件.
- 关于将这些技术整合到结核病控制工作中,存在一个知识差距.
- 这项研究综合了现有证据,以解决这一差距.
研究的目的:
- 探索电子系统和文本挖掘软件的实用性,以支持终结结核病战略.
- 综合有关控制和管理结核病 (TB) 的干预措施的证据.
- 制定改善结核病预防和患者护理的框架.
主要方法:
- 在PubMed数据库上进行了系统的文献搜索,搜索自2012年以来出版的英语评论文章.
- 925篇文章符合结核病控制和管理干预措施的纳入标准.
- 使用文本和内容分析软件 (Leximancer) 来合成包含的文章,从频率和热图中识别主题.
主要成果:
- 制定了一个框架,重点关注早期检测和治疗,以尽量减少结核病的传播.
- 该框架强调了查和治疗领域,特别是在敏感人群中.
- 所生成的框架与世界卫生组织的结核病终结战略一致,促进以患者为中心的方法.
结论:
- 该研究为指导结核病实践,政策制定和未来研究提供了一个框架.
- 研究结果强调了以患者为中心的结核病预防和保护弱势群体的重要性.
- 未来的研究应该进一步阐述框架,并通过利益相关者的反来评估其实用性.
相关概念视频
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.


